Published in Proc Natl Acad Sci U S A on August 04, 1998
Inflammation and cancer. Nature (2002) 53.78
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell (2011) 6.21
Contribution of platelets to tumour metastasis. Nat Rev Cancer (2011) 4.16
Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood (2007) 3.32
Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci U S A (2002) 3.10
Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A (2001) 3.04
Mammalian glycosylation in immunity. Nat Rev Immunol (2008) 2.74
Platelet alpha-granules: basic biology and clinical correlates. Blood Rev (2009) 2.72
Inflammatory cells and cancer: think different! J Exp Med (2001) 2.42
Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol (2004) 2.01
Platelets increase the proliferation of ovarian cancer cells. Blood (2012) 1.97
Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol (2004) 1.76
Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest (2003) 1.73
Platelet glycoprotein Ib alpha supports experimental lung metastasis. Proc Natl Acad Sci U S A (2007) 1.68
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood (2010) 1.67
Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin. Biophys J (2000) 1.65
Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol (2012) 1.58
Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med (2003) 1.58
Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem (2008) 1.51
CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer (2003) 1.49
The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis. Am J Pathol (2007) 1.46
The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov (2012) 1.40
Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS One (2011) 1.38
The chemical neurobiology of carbohydrates. Chem Rev (2008) 1.33
Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins. Proc Natl Acad Sci U S A (2004) 1.33
Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol (1999) 1.29
Platelets: linking hemostasis and cancer. Arterioscler Thromb Vasc Biol (2010) 1.29
ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg (2005) 1.27
Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells. Am J Physiol Cell Physiol (2008) 1.23
Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells. Exp Cell Res (2008) 1.14
Targeting tumor-stromal interactions in bone metastasis. Pharmacol Ther (2013) 1.12
E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. Br J Cancer (2009) 1.12
PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells. Neoplasia (2013) 1.11
Specificity in cancer immunotherapy. Semin Immunol (2008) 1.11
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res (2011) 1.11
Protein glycosylation in cancer. Annu Rev Pathol (2015) 1.11
Platelets at the interface of thrombosis, inflammation, and cancer. Blood (2015) 1.11
Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol (2011) 1.10
Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Thromb Haemost (2006) 1.09
Integrins and bone metastasis: integrating tumor cell and stromal cell interactions. Bone (2010) 1.09
Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev (2014) 1.07
Are selectins involved in metastasis? Clin Exp Metastasis (1999) 1.04
Targeted glycoproteomic identification of cancer cell glycosylation. Glycobiology (2009) 1.02
Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood (2014) 1.02
Prognostic significance of CD24 expression in gastric carcinoma. Cancer Res Treat (2004) 1.01
Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase. Neoplasia (2011) 0.99
Single-molecule binding of CD44 to fibrin versus P-selectin predicts their distinct shear-dependent interactions in cancer. J Cell Sci (2011) 0.96
Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin. Oncol Rep (2013) 0.96
Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap. Br J Pharmacol (2011) 0.92
P-selectin-mediated platelet adhesion promotes the metastasis of murine melanoma cells. PLoS One (2014) 0.90
Differential platelet levels affect response to taxane-based therapy in ovarian cancer. Clin Cancer Res (2014) 0.89
CD44 and HCELL: preventing hematogenous metastasis at step 1. FEBS Lett (2011) 0.88
Glycosylation and liver cancer. Adv Cancer Res (2015) 0.88
Regulation of hematogenous tumor metastasis by acid sphingomyelinase. EMBO Mol Med (2015) 0.88
Sialylated Lewis x antigen bearing glycoproteins in human plasma. J Proteome Res (2010) 0.87
Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cells. Proc Natl Acad Sci U S A (2009) 0.86
Increased platelet reactivity in patients with late-stage metastatic cancer. Cancer Med (2013) 0.86
P-Selectin-Mediated Adhesion between Platelets and Tumor Cells Promotes Intestinal Tumorigenesis in Apc(Min/+) Mice. Int J Biol Sci (2015) 0.86
Expression of ST3GAL4 leads to SLe(x) expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cells. PLoS One (2013) 0.84
Cell adhesion molecules in metastatic neuroblastoma models. Clin Exp Metastasis (2014) 0.84
Platelet P2Y12 is involved in murine pulmonary metastasis. PLoS One (2013) 0.84
The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas. BMC Cancer (2009) 0.84
Overexpression of alpha(1,3)-fucosyltransferase VII is sufficient for the acquisition of lung colonization phenotype in human lung adenocarcinoma HAL-24Luc cells. Br J Cancer (1999) 0.84
P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin. Exp Cell Res (2006) 0.83
Living in shear: platelets protect cancer cells from shear induced damage. Clin Exp Metastasis (2014) 0.82
Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung. Clin Exp Metastasis (2008) 0.82
P-selectin-mediated platelet adhesion promotes tumor growth. Oncotarget (2015) 0.81
Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1. Front Oncol (2014) 0.81
NF-E2 p45 is important for establishing normal function of platelets. Mol Cell Biol (2013) 0.81
CHST11 gene expression and DNA methylation in breast cancer. Int J Oncol (2015) 0.79
Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin. J Cancer Res Clin Oncol (2005) 0.79
Malignant melanoma as a target malignancy for the study of the anti-metastatic properties of the heparins. Cancer Metastasis Rev (2010) 0.78
Interaction between circulating cancer cells and platelets: clinical implication. Chin J Cancer Res (2015) 0.78
Targeting Underglycosylated MUC1 for the Selective Capture of Highly Metastatic Breast Cancer Cells Under Flow. Cell Mol Bioeng (2013) 0.78
Two by two: the pairings of P-selectin and P-selectin glycoprotein ligand 1. Proc Natl Acad Sci U S A (2001) 0.77
Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process. Clin Exp Metastasis (2015) 0.77
Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. Cancer Prev Res (Phila) (2016) 0.76
miR-301a expression: A prognostic marker for prostate cancer. Urol Oncol (2016) 0.76
Complete enzymic synthesis of the mucin-type sialyl Lewis x epitope, involved in the interaction between PSGL-1 and P-selectin. Glycoconj J (1999) 0.76
Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model. Oncol Lett (2015) 0.76
Analytical cell adhesion chromatography reveals impaired persistence of metastatic cell rolling adhesion to P-selectin. J Cell Sci (2015) 0.76
ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets. Cell Death Differ (2017) 0.75
Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues. PLoS One (2017) 0.75
The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? Ther Adv Med Oncol (2016) 0.75
N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation. Drug Des Devel Ther (2017) 0.75
Mass Spectrometry-Based N-Glycomics of Colorectal Cancer. Int J Mol Sci (2015) 0.75
N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma. Sci Rep (2016) 0.75
C-type lectins facilitate tumor metastasis. Oncol Lett (2016) 0.75
Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence. Reprod Biol Endocrinol (2016) 0.75
Targeting Selectins and Their Ligands in Cancer. Front Oncol (2016) 0.75
Sialylation of N-glycans: mechanism, cellular compartmentalization and function. Histochem Cell Biol (2016) 0.75
Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets. Clin Exp Metastasis (2016) 0.75
The role of mucin-educated platelet activation in tumor invasiveness: An unfolding concern in the realm of cancer biology. Biomedicine (Taipei) (2017) 0.75
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell (1992) 17.50
Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol (1995) 7.16
Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell (1993) 6.05
Selectins and their ligands: current concepts and controversies. Blood (1996) 5.78
Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res (1990) 5.41
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res (1996) 3.73
Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest (1997) 2.75
Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res (1993) 2.39
Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J (1997) 2.21
CD62/P-selectin recognition of myeloid and tumor cell sulfatides. Cell (1991) 2.16
Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci (1992) 2.11
Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest (1998) 1.97
Possible roles of tumor-associated carbohydrate antigens. Cancer Res (1996) 1.90
Mucin glycoproteins in neoplasia. Glycoconj J (1996) 1.81
Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev (1992) 1.67
Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J (1997) 1.65
Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem (1994) 1.57
Selectin ligands: will the real ones please stand up? J Clin Invest (1997) 1.56
Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J (1997) 1.54
Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res (1995) 1.48
Role of platelets in tumor cell metastases. Ann Intern Med (1981) 1.46
Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol (1993) 1.40
P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest (1993) 1.37
Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev (1984) 1.34
Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis (1995) 1.34
Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines. Proc Natl Acad Sci U S A (1992) 1.32
Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res (1989) 1.32
Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest (1991) 1.32
Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med (1996) 1.27
A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature (1993) 1.27
Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells. Exp Cell Res (1995) 1.25
Analysis of the inhibition of tumour metastasis by sulphated polysaccharides. Int J Cancer (1987) 1.11
Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity. Cancer Res (1992) 1.10
Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis. Dis Colon Rectum (1997) 1.10
Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. Glycobiology (1996) 1.07
Genetic manipulation of vascular adhesion molecules in mice. J Clin Invest (1996) 1.06
Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer (1995) 1.06
Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases. Lab Invest (1990) 0.99
Chromosomal assignment of human YAC clones by fluorescence in situ hybridization: use of single-yeast-colony PCR and multiple labeling. Genomics (1992) 0.97
Tumor cell surface carbohydrate and the metastatic phenotype. Cancer Metastasis Rev (1987) 0.96
Therapeutic inhibition of carbohydrate-protein interactions in vivo. J Clin Invest (1997) 0.96
Carbohydrate signals in metastasis and prognosis of human carcinomas. Glycobiology (1993) 0.94
Treatment with modified heparins inhibits experimental metastasis formation and leads, in some animals, to long-term survival. Invasion Metastasis (1996) 0.93
Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26. Cancer Res (1995) 0.92
Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer. J Clin Oncol (1997) 0.90
Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis. Cancer Metastasis Rev (1984) 0.89
A novel detection system for submicroscopic human metastases in athymic mice. Cancer Commun (1991) 0.89
Selectin ligands on human melanoma cells. Glycoconj J (1996) 0.84
Expression of a carbohydrate signal, sialyl dimeric Le(x) antigen, is associated with metastatic potential of transitional cell carcinoma of the human urinary bladder. Biochem Biophys Res Commun (1991) 0.84
Analysis of the Lewisx epitope in human pancreas and pancreatic adenocarcinomas. Int J Pancreatol (1992) 0.82
Process of dispersion and fragmentation of Golgi complex by microtubule bundles formed in taxol treated HeLa cells. Cell Struct Funct (1997) 0.81
Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity. J Clin Invest (1981) 3.34
A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci U S A (1998) 3.26
Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A (2001) 3.04
Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol (1992) 2.98
GMP-140 binds to a glycoprotein receptor on human neutrophils: evidence for a lectin-like interaction. J Cell Biol (1991) 2.82
Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology (1999) 2.67
A primate genome project deserves high priority. Science (2000) 2.36
Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J (1997) 2.21
Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res (1984) 2.01
Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest (1998) 1.97
Structural studies of phosphorylated high mannose-type oligosaccharides. J Biol Chem (1980) 1.90
The spectrum of anionic oligosaccharides released by endo-beta-N-acetylglucosaminidase H from glycoproteins. Structural studies and interactions with the phosphomannosyl receptor. J Biol Chem (1983) 1.89
The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity (2000) 1.83
Ras activation in human breast cancer. Breast Cancer Res Treat (2000) 1.83
Characterization of a specific ligand for P-selectin on myeloid cells. A minor glycoprotein with sialylated O-linked oligosaccharides. J Biol Chem (1993) 1.82
Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol (2001) 1.81
Identification of a rat liver alpha-N-acetylglucosaminyl phosphodiesterase capable of removing "blocking" alpha-N-acetylglucosamine residues from phosphorylated high mannose oligosaccharides of lysosomal enzymes. J Biol Chem (1980) 1.73
Siglecs, sialic acids and innate immunity. Trends Immunol (2001) 1.73
Genetic differences between humans and great apes. Mol Phylogenet Evol (2001) 1.67
A structural difference between the cell surfaces of humans and the great apes. Am J Phys Anthropol (1998) 1.67
Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow. J Natl Cancer Inst (1997) 1.64
Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy. Blood (1998) 1.64
Proteomic comparison of human and great ape blood plasma reveals conserved glycosylation and differences in thyroid hormone metabolism. Am J Phys Anthropol (2001) 1.62
Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci U S A (1998) 1.57
The selectin GMP-140 binds to sialylated, fucosylated lactosaminoglycans on both myeloid and nonmyeloid cells. J Cell Biol (1991) 1.53
Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology (1999) 1.53
Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. J Thromb Haemost (2011) 1.52
Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition. J Biol Chem (1993) 1.49
Alu-mediated inactivation of the human CMP- N-acetylneuraminic acid hydroxylase gene. Proc Natl Acad Sci U S A (2001) 1.49
Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res (1995) 1.48
Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. Cancer Res (1984) 1.48
CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J Biol Chem (1993) 1.46
A neuraminidase from Streptococcus sanguis that can release O-acetylated sialic acids. J Biol Chem (1983) 1.45
Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol (2001) 1.45
The times they are a'changin': changing with the times. J Clin Invest (1992) 1.43
Siglecs in the immune system. Immunology (2001) 1.42
Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology (2001) 1.41
OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily. J Biol Chem (1999) 1.41
Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs. J Biol Chem (2000) 1.36
Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways. J Biol Chem (2000) 1.35
Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters. J Biol Chem (2001) 1.34
Purification and characterization of rat liver alpha-N-acetylglucosaminyl phosphodiesterase. J Biol Chem (1981) 1.34
Calcium-dependent heparin-like ligands for L-selectin in nonlymphoid endothelial cells. Science (1993) 1.34
A monoclonal antibody recognizes an O-acylated sialic acid in a human melanoma-associated ganglioside. J Biol Chem (1984) 1.31
Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol (1999) 1.29
DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. J Clin Invest (1996) 1.28
Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma. Cancer Commun (1990) 1.27
The oligosaccharide binding specificities of CD22 beta, a sialic acid-specific lectin of B cells. J Biol Chem (1994) 1.26
Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. Glycobiology (1999) 1.25
I-type lectins. J Biol Chem (1995) 1.24
Cytokine-induced beta-galactoside alpha-2,6-sialyltransferase in human endothelial cells mediates alpha 2,6-sialylation of adhesion molecules and CD22 ligands. J Biol Chem (1994) 1.24
The release and purification of sialic acids from glycoconjugates: methods to minimize the loss and migration of O-acetyl groups. Anal Biochem (1984) 1.23
P-selectin mediates the adhesion of sickle erythrocytes to the endothelium. Blood (2001) 1.23
Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy. Cancer Res (1997) 1.22
Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids. J Cell Biol (1994) 1.22
Siglecs: a family of sialic-acid binding lectins. Glycobiology (1998) 1.22
New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins. J Biol Chem (2000) 1.20
Biosynthesis of N-glycolyneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool. J Biol Chem (1989) 1.18
IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J Immunol (2001) 1.16
High level O-acetylation of sialic acids on N-linked oligosaccharides of rat liver membranes. Differential subcellular distribution of 7- and 9-O-acetyl groups and of enzymes involved in their regulation. J Biol Chem (1993) 1.15
Demonstration of the heterozygous state for I-cell disease and pseudo-Hurler polydystrophy by assay of N-acetylglucosaminylphosphotransferase in white blood cells and fibroblasts. Am J Hum Genet (1982) 1.15
Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. Clin Cancer Res (2000) 1.13
High-pressure liquid chromatography of sialic acids on a pellicular resin anion-exchange column with pulsed amperometric detection: a comparison with six other systems. Anal Biochem (1990) 1.13
Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann N Y Acad Sci (1999) 1.12
Carbohydrate-deficient glycoprotein syndrome: not an N-linked oligosaccharide processing defect, but an abnormality in lipid-linked oligosaccharide biosynthesis? J Clin Invest (1994) 1.11
Exploring the glycan repertoire of genetically modified mice by isolation and profiling of the major glycan classes and nano-NMR analysis of glycan mixtures. Glycobiology (2000) 1.11
Developmental abnormalities in transgenic mice expressing a sialic acid-specific 9-O-acetylesterase. Cell (1991) 1.11
CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins. J Biol Chem (1995) 1.10
Disappearing physician-scientists. Science (1999) 1.09
Selective inactivation of influenza C esterase: a probe for detecting 9-O-acetylated sialic acids. Science (1987) 1.09
Endothelial heparan sulfate proteoglycans that bind to L-selectin have glucosamine residues with unsubstituted amino groups. J Biol Chem (1995) 1.08
Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis. Oncogene (2010) 1.07
Biosynthesis and turnover of O-acetyl and N-acetyl groups in the gangliosides of human melanoma cells. J Biol Chem (1990) 1.07
Sulfated N-linked oligosaccharides in mammalian cells. I. Complex-type chains with sialic acids and O-sulfate esters. J Biol Chem (1988) 1.06
Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily. Glycobiology (2000) 1.03
The spectrum of incomplete N-linked oligosaccharides synthesized by endothelial cells in the presence of brefeldin A. J Biol Chem (1992) 1.03
Studies of naturally occurring modifications of sialic acids by fast-atom bombardment-mass spectrometry. Analysis of positional isomers by periodate cleavage. J Biol Chem (1990) 1.02
Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma. Proc Natl Acad Sci U S A (1998) 1.02
A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. J Clin Invest (1998) 1.02
Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin. J Biol Chem (1995) 1.01
A novel anionic modification of N-glycans on mammalian endothelial cells is recognized by activated neutrophils and modulates acute inflammatory responses. J Immunol (2001) 1.01
Structures of sialylated fucosyl polylactosaminoglycans isolated from chronic myelogenous leukemia cells. J Biol Chem (1985) 1.01
Isolation of Clostridium difficile from hospitalized patients without antibiotic-associated diarrhea or colitis. J Clin Microbiol (1982) 1.00
Calcium-dependent oligonucleotide antagonists specific for L-selectin. Proc Natl Acad Sci U S A (1996) 0.99
Steps in the phosphorylation of the high mannose oligosaccharides of lysosomal enzymes. Ciba Found Symp (1982) 0.99
9-O-acetylated sialic acids have widespread but selective expression: analysis using a chimeric dual-function probe derived from influenza C hemagglutinin-esterase. Proc Natl Acad Sci U S A (1994) 0.99
Sialic acid 9-O-acetylation on murine erythroleukemia cells affects complement activation, binding to I-type lectins, and tissue homing. J Biol Chem (1996) 0.98
Enhanced interaction of L-selectin with the high endothelial venule ligand via selectively oxidized sialic acids. Proc Natl Acad Sci U S A (1993) 0.98
Lysosomal and cytosolic sialic acid 9-O-acetylesterase activities can Be encoded by one gene via differential usage of a signal peptide-encoding exon at the N terminus. J Biol Chem (1999) 0.97